Hereditary angioedema: A current state-of-the-art review, V: Attenuated androgens for the treatment of hereditary angioedema

Annals of Allergy, Asthma and Immunology

Volumn 100, Issue 1 SUPPL. 2, 2008, Pages

  Banerji, Aleena ^a   Sloane, David E ^b   Sheffer, Albert L ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4; DANAZOL; FRESH FROZEN PLASMA; LIPID; METHYLTESTOSTERONE; OXANDROLONE; OXYMETHOLONE; STANOZOLOL;

ACNE; AGGRESSION; ALOPECIA; ANGIONEUROTIC EDEMA; ATHEROSCLEROSIS; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; CREATINE KINASE BLOOD LEVEL; DEPRESSION; DIZZINESS; DRUG ABSORPTION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; GYNECOMASTIA; HEADACHE; HEMATURIA; HIRSUTISM; HUMAN; LIPID ANALYSIS; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER NECROSIS; LONG TERM CARE; LOW DRUG DOSE; MALIGNANT NEOPLASTIC DISEASE; MENSTRUAL IRREGULARITY; MYALGIA; OBSTRUCTIVE JAUNDICE; PREGNANCY; PRIORITY JOURNAL; SAFETY; SHORT COURSE THERAPY; SIDE EFFECT; UNITED STATES; VIRILIZATION; VOMITING; WATER RETENTION; WEIGHT GAIN;

EID: 38049016296     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60582-0     Document Type: Conference Paper

References (33)

1. Zuraw BL. Current and future therapy for hereditary angioedema. Clin Immunol. 2005;114:10-16.
2. Fay A, Abinun M. Current management of hereditary angio-oedema (C' 1 esterase inhibitor deficiency). J Clin Pathol. 2002;55:266-270.
3. Agostoni A, Cicardi M, Martignoni GC, Bergamaschini L, Marasini B. Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema. J Allergy Clin Immunol. 1980;65:75-79.
4. Castro-Magana M, Cheruvanky T, Collipp PJ, Ghavami-Maibodi Z, Angulo M, Stewart C. Transient adrenogenital syndrome due to exposure to danazol in utero. Am J Dis Child. 1981;135:1032-1034.
5. Schwartz R. Ambiguous genitalia in a term female infant due to exposure to danazol in utero. Am J Dis Child. 1982;136:474.
6. Bragiel I, Wozniewska M, Ludwiczak H. Correction of deficiency of C1 esterase inhibitor in angioneurotic edema with oxymetholone. Pol Arch Med Wewn. 1980;64:551-558.
7. Sheffer AL, Fearon DT, Austen KF. Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema. J Allergy Clin Immunol. 1979;64:275-280.
8. Prada AE, Zahedi K, Davis AE 3rd. Regulation of C1 inhibitor synthesis. Immunobiology. 1998;199:377-388.
9. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001;161:2417-2429.
10. Frank MM. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am. 2006;26:653-668.
11. Spaulding WB. Hereditary angioneurotic edema in two families. Can Med Assoc J. 1960;73:1955.
12. Sheffer AL, Fearon DT, Austen KF. Methyltestosterone therapy in hereditary angioedema. Ann Intern Med. 1977;86:306-308.
13. Gelfand JA, Sherins RJ, Alling DW, Frank MM. Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities. N Engl J Med. 1976;295:1444-1448.
14. MacFarlane JT, Davies D. Management of hereditary angio-oedema with low-dose danazol. Br Med J (Clin Res Ed). 1981;282:1275.
15. Hosea SW, Santaella ML, Brown EJ, Berger M, Katusha K, Frank MM. Long-term therapy of hereditary angioedema with danazol. Ann Intern Med. 1980;93:809-812.
16. Zurlo JJ, Frank MM. The long-term safety of danazol in women with hereditary angioedema. Fertil Steril. 1990;54:64-72.
17. Cicardi M, Bergamaschini L, Cugno M, Hack E, Agostoni G, Agostoni A. Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. J Allergy Clin Immunol. 1991;87:768-773.
18. Brunskill PJ. The effects of fetal exposure to danazol. Br J Obstet Gynaecol. 1992;99:212-215.
19. Szeplaki G, Varga L, Valentin S, et al. Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J Allergy Clin Immunol. 2005;115:864-869.
20. Chang JC, Slutzker B, Lindsay N. Remission of pure red cell aplasia following oxymetholone therapy. Am J Med Sci. 1978;275:345-351.
21. Davis PJ, Davis FB, Charache P. Long-term therapy of hereditary angioedema (HAE): preventive management with fluoxymesterone and oxymetholone in severely affected males and females. Johns Hopkins Med J. 1974;135:391-398.
22. Davis PJ, Davis FB, Charache P. Hereditary angioedema: modification of clinical manifestations with androgens. Birth Defects Orig Artic Ser. 1976;12:283-287.
23. Yamato H, Nakashima Y, Ninomiya K, Sakurai S, Kuroiwa A. A familial case of hereditary angioneurotic edema in Japan. Intern Med. 1992;31:353-356.
24. Rubegni P, Flori ML, Fimiani M, Andreassi L. A case of cryofibrinogenaemia responsive to stanozolol. Br J Haematol. 1996;93:217-219.
25. Berger JR, Pall L, Winfield D. Effect of anabolic steroids on HIV-related wasting myopathy. South Med J. 1993;86:865-866.
26. Sheffer AL, Fearon DT, Austen KF. Clinical and biochemical effects of stanozolol therapy for hereditary angioedema. J Allergy Clin Immunol. 1981;68:181-187.
27. Sheffer AL, Fearon DT, Austen KF. Hereditary angioedema: a decade of management with stanozolol. J Allergy Clin Immunol. 1987;80:855-860.
28. Sloane DE, Lee CW, Sheffer AL. Hereditary angioedema: safety of long-term stanozolol therapy. J Allergy Clin Immunol. 2007;120:654-658.
29. Spooner JB. Classification of side-effects to danazol therapy. J Int Med Res. 1977;5(suppl 3):15-17.
30. Smith CS, Harris F. Preliminary experience with danazol in children with precocious puberty. J Int Med Res. 1977;5(suppl 3):109-113.
31. Farkas H, Harmat G, Fust G, Varga L, Visy B. Clinical management of hereditary angio-oedema in children. Pediatr Allergy Immunol. 2002;13:153-161.
32. Tappeiner G, Hintner H, Glatzl J, Wolff K. Hereditary angio-oedema: treatment with danazol: report of a case. Br J Dermatol. 1979;100:207-212.
33. Church JA. Oxandrolone treatment of childhood hereditary angioedema. Ann Allergy Asthma Immunol. 2004;92:377-378.